Clear Impact logo

Vermont Medicaid

Logo

COL: Colorectal Cancer Screening - Age 46-75 (ACS-MY)

Current Value

31.0%

MY 2023

Definition

Line Bar

Notes on Methodology

  • This is a Healthcare Effectiveness & Data Information Set (HEDIS®) administrative measure and only includes Medicaid Primary beneficiaries.
  • The annual reported rate captures activity during the stated measurement year (MY).

The Healthcare Effectiveness Data and Information Set (HEDIS®) is a registered trademark of NCQA.

Story Behind the Curve

This measure assesses the percentage of members 46–75 years of age who had appropriate screening for colorectal cancer using any of the following tests:

  • Fecal occult blood test (FOBT) during the measurement year.
  • Flexible sigmoidoscopy during the measurement year or the 4 years before the measurement year.
  • Colonoscopy during the measurement year or the 9 years before the measurement year.
  • CT colonography during the measurement year or the 4 years before the measurement year.
  • Stool DNA (sDNA) with FIT test during the measurement year or the 2 years prior to the measurement year.

Clear Impact Suite is an easy-to-use, web-based software platform that helps your staff collaborate with external stakeholders and community partners by utilizing the combination of data collection, performance reporting, and program planning.

Scorecard Container Measure Action Actual Value Target Value Tag S A m/d/yy m/d/yyyy